[Cambendazole - a new substance for the treatment of strongyloidiasis].
The Author studied the therapeutic activity of a new drug - Cambendazole, in the treatment of 100 children suffering from strongyloidiasis infection. The patients received a single dose of the 5 mg per K of body weight, and laboratorial controls were made in the 7th, 8th, 9th, and 10th after the treatment and consisting of Berman-Moraes method.
D001562:Benzimidazoles / Q000627:therapeutic use*; D002159:Cambendazole / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D013322:Strongyloidiasis / Q000188:drug therapy*
D001562:Benzimidazoles; D002159:Cambendazole
Cambendazole - nova substancia para o tratamento da estrongiloidíase.